Showing 2771-2780 of 9938 results for "".
What’s Old is New: Cosmetic Trends for 2020
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/whats-old-is-new-cosmetic-trends-for-2020/23193/Experts go back to basics for best results.Type Casting: Assessing Personality Before a Hire
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/type-casting-assessing-personality-before-a-hire/22994/Can the Myers–Briggs Type Indicator take the guess work out of your next hiring decision?From the Neck Down
https://practicaldermatology.com/topics/practice-management/from-the-neck-down/20781/Exploring other uses for Allergan's KybellaMedical Credentialing
https://practicaldermatology.com/topics/practice-management/medical-credentialing/20948/You can help distinguish yourself from the masses by highlighting the unique credentials of your team.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-2/23000/Teledermatology Use during the COVID-19 Pandemic
https://practicaldermatology.com/columns/clinical-focus-1/teledermatology-use-during-the-covid-19-pandemic/23769/Despite challenges, the future of teledermatology is promising.An Update on the Use of Trifarotene for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/an-update-on-the-use-of-trifarotene-for-the-treatment-of-acne/23267/Trifarotene is the first novel topical retinoid approved for the treatment of facial and truncal acne in 20 years.Viewpoint: What Does Private Equity in Dermatology Mean for Residents and Millennial Dermatologists?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/viewpoint-what-does-private-equity-in-dermatology-mean-for-residents-and-millennial-dermatologists/23107/One resident’s take on the pros and cons of PE-backed employment and other opportunities for new dermatologists.Know Your Pigmented Lesions
https://practicaldermatology.com/youngmd-connect/resident-resource-center/know-your-pigmented-lesions/23560/A diagnostic challenge and review of a rare melanocytic lesion.Case Report: First Reported Case of Facial Rash After Dupilumab Therapy; Call for Abstracts
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-first-reported-case-of-facial-rash-after-dupilumab-therapy-call-for-abstracts/20499/